Keen Vision Acquisition Corp

Keen Vision Acquisition Corp(KVAC)股票分析

$11.510

-1.511 (-13.13%)收盤時

Loading chart…
High
12.000
Open
11.925
VWAP
11.67
Vol
35.17K
Mkt Cap
205.09M
Low
11.510
Amount
410.54K
EV/EBITDA, TTM
0.00

Keen Vision Acquisition Corporation is a blank check company. The Company is formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing all or substantially all the assets of, entering into contractual arrangements, or engaging in any other similar business combination with one or more businesses. The Company is an early-stage company and an emerging growth company. The Company has neither engaged in any operations nor generated any revenues.

www.kv-ac.com

估值指標

The current forward P/E ratio for Keen Vision Acquisition Corp (KVAC) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
高估
0.00
低估
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
高估
0.00
低估
0.00

Forward P/S

Fair
5Y Average P/S
0.11
Current P/S
0.00
高估
1.22
低估
-1.01

Alphio AI Price Scenarios for KVAC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%KVAC

$14.38

情境價格

B

Base

Base · 50%KVAC

$13.67

情境價格

B

Bear

Bear · 25%KVAC

$12.96

情境價格

Whales holding KVAC

W

W. R. Berkley Corporation

+ HoldingKVAC

-0.55%

3M Return

事件時間軸

2025-07-15 (ET)

08:04:56

Medera, University of Kansas report first patient treated in gene therapy trial

2025-06-24 (ET)

08:10:28

Medera, Novoheart announce collaboration with scientists at University of CA

2025-06-13 (ET)

08:06:33

Medera, Novoheart present breakthroughs in human mini-heart platforms, therapy

2025-05-19 (ET)

08:15:18

Medera showcases interim data from first-in-human gene therapy trial

2025-04-01 (ET)

08:05:55

Medera presents updated results from gene therapy trial for heart failure

資訊

KVAC FAQ — answered by Alphio AI

Keen Vision Acquisition Corporation is a blank check company. The Company is formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing all or substantially all the assets of, entering into contractual arrangements, or engaging in any other similar business combination with one or more businesses. The Company is an early-stage company and an emerging growth company. The Company has neither engaged in any operations nor generated any revenues. It operates in the Financials sector (BLANK CHECKS industry).

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始